Evidence map›Paper›PMID 42494416›Full record

ReviewMaterials today. Bio2026

Surface bioengineering of lanthanide nanoparticles for theranostic applications: From hydrophilic modification to multimodal imaging and therapy.

Xuan Tan, Yunqiu Zhang, Shuping Wu, Dengyu Ma, Jinyu Yan, Jinwei Lu, Shikai Lin, Shiyan Li, Zhexin Hong, Shihui Jiang and 1 more

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xuan TanSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Yunqiu ZhangSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Shuping WuSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Dengyu MaSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Jinyu YanSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Jinwei LuSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Shikai LinSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Shiyan LiSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Zhexin HongSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.
Shihui JiangState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 350002, China.
Guowei LiSchool of Medical Imaging, Fujian Medical University, Fuzhou, Fujian, 350122, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lanthanide nanoparticles (LnNPs) are recognized as next-generation luminescent bioprobes due to their tunable emission spectra, long luminescence lifetimes, and high photostability. Although extensively studied, these nanomaterials have recently garnered renewed interest across biodetection, bioimaging, and therapeutics. To serve as suitable optical labels, LnNPs need to overcome inherent limitations such as hydrophobic surfaces, insufficient luminescence intensity, and limited environmental responsiveness. Accordingly, the integration of optical modulation, hydrophilic surface modification, and biofunctionality has become essential for advancing their biomedical applications. Recent surface engineering strategies have systematically addressed challenges related to hydrophilicity, colloidal stability, and biocompatibility, with substantial progress achieved. This review outlines mainstream approaches for hydrophilic surface modification and bio-functionalization of LnNPs, including ligand engineering, surface coating, and biomimetic modification. The design rationale and implementation of these methods are discussed, alongside representative applications in multimodal imaging and targeted therapy. Current challenges and future prospects in this rapidly evolving field are also summarized.

Indexed as

Bio-functionalizationHydrophilic modificationLanthanide nanoparticlesSurface bioengineeringTheranostics

Identifiers

PMID42494416
PMCPMC13392567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.